🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Trafermin is a recombinant human basic fibroblast growth factor (bFGF; orig...
Status
Completed
Location
Multiple Locations
Start Date
2010-11
Trial ID
NCT01217463
Treatments Being Tested
The present clinical trial clarified that basic fibroblast growth factor-2 ...
Status
Completed
Location
Multiple Locations
Start Date
2001-12
Trial ID
NCT00514657
Treatments Being Tested
This study aims to investigate the safety in using Trafermin (recombinant h...
Status
Completed
Location
Kaken Investigational Site 5
Start Date
2009-11
Trial ID
NCT01015404
Treatments Being Tested
To assess the efficacy and safety of the regeneration treatment of tympanic...
Status
Completed
Location
Multiple Locations
Start Date
2015-03
Trial ID
NCT02550314
Treatments Being Tested
This study aims to verify the effectiveness of Trafermin (recombinant human...
Status
Completed
Location
Kaken Investigational Site
Start Date
2008-08
Trial ID
NCT00734708
Treatments Being Tested
Trafermin is a recombinant human basic fibroblast growth factor (bFGF; orig...
Status
Completed
Location
Multiple Locations
Start Date
2010-12
Trial ID
NCT01217476
Treatments Being Tested
This study is designed to evaluate the efficacy and the safety of Trafermin...
Status
Completed
Location
Kaken Investigational Site
Start Date
2005-08
Trial ID
NCT00199290
Treatments Being Tested